// App-Quantinova.ai

418 : Mitochondrial perturbations as a novel approach to personalized medicine

Researchers

Presenter

  • shruti bhatt

Principal Investigators

  • david weinstock

  • Anthony Letai

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • GC Vitamin D Binding Protein

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved